Scholarlink

Background <p>The etiology of keratoconus, a disease characterized by deterioration in the extracellular matrix and thinning of the corneal stroma, has not yet been fully elucidated. Recent studies have drawn attention to the relationship between TGF-<i>β</i>1 (Transforming Growth Factor Beta-1) and keratoconus because of its essential role in extracellular matrix secretion.</p> Aims <p>This study aimed to assess serum TGF-<i>β</i>1 levels in keratoconus patients and demonstrate its potential for estimating the severity of the disease.</p> Materials and methods <p>The study prospectively included 63 patients diagnosed with keratoconus, followed-up between October 2023 and May 2024, and 65 healthy individuals. Patients were divided into four groups according to the Amsler–Krumeich classification. Serum TGF-<i>β</i>1 levels were measured from venous blood samples taken from the patient and control groups using ELISA.</p> Results <p>In the patient group, TGF-<i>β</i>1 levels were 357.13&#xa0;pg/ml (165.43–793.91) and 233.71&#xa0;pg/ml (117.95–583.72) in the control group. TGF-<i>β</i>1 levels in the patient group were significantly higher than in the control group (<i>p</i> = 0.001). When keratoconus was examined according to stage, it was determined that TGF-<i>β</i>1 levels increased as the severity of the disease increased (<i>p</i> &lt; 0.05 for all groups). No statistical difference was found between the groups in terms of age and gender.</p> Conclusion <p>Considering that TGF-<i>β</i>1 is effective in the formation of fibrosis, high TGF-<i>β</i>1 levels may play a role in the scar formation observed in the advanced stages of keratoconus patients.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

The role of transforming growth factor beta-1 (TGF-β1) in the development of fibrosis in keratoconus

  • 期刊论文

  • 发表日期：

    2025年8月6日

查看全文
  • Mustafa Yildirim

摘要

Background

The etiology of keratoconus, a disease characterized by deterioration in the extracellular matrix and thinning of the corneal stroma, has not yet been fully elucidated. Recent studies have drawn attention to the relationship between TGF-β1 (Transforming Growth Factor Beta-1) and keratoconus because of its essential role in extracellular matrix secretion.

Aims

This study aimed to assess serum TGF-β1 levels in keratoconus patients and demonstrate its potential for estimating the severity of the disease.

Materials and methods

The study prospectively included 63 patients diagnosed with keratoconus, followed-up between October 2023 and May 2024, and 65 healthy individuals. Patients were divided into four groups according to the Amsler–Krumeich classification. Serum TGF-β1 levels were measured from venous blood samples taken from the patient and control groups using ELISA.

Results

In the patient group, TGF-β1 levels were 357.13 pg/ml (165.43–793.91) and 233.71 pg/ml (117.95–583.72) in the control group. TGF-β1 levels in the patient group were significantly higher than in the control group (p = 0.001). When keratoconus was examined according to stage, it was determined that TGF-β1 levels increased as the severity of the disease increased (p < 0.05 for all groups). No statistical difference was found between the groups in terms of age and gender.

Conclusion

Considering that TGF-β1 is effective in the formation of fibrosis, high TGF-β1 levels may play a role in the scar formation observed in the advanced stages of keratoconus patients.